Provider
QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations
Program effective Date: Nov 11, 2020
Documents & Forms Results
Displaying 2211 - 2220 of 3108 results
Provider
QP109-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Antiemetic Agents
Program effective Date: Nov 11, 2020
Provider
P50R2-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment and Post-Acute Care Services for Medicare Advantage Subscribers
Program effective Date: Nov 02, 2020
Provider
P49R1-20 CERiS Review of High Dollar Claims
Program effective Date: Nov 02, 2020
Provider
P78-20 Reminder: New Prior Authorization Timeframes Required by Legislation
Program effective Date: Nov 02, 2020
Provider
P84-20 Predetermination Request Form for Commercial Lines of Business
Program effective Date: Nov 02, 2020
Provider
P86-20 Appeals Policy for no Prior Authorization for Minnesota Health Care Programs
Program effective Date: Nov 02, 2020
Provider
2020 November Bulletins
Program effective Date: Nov 02, 2020
Provider
P82-20 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Nov 02, 2020
Provider
P79-20 Change in Medical Necessity Criteria to InterQual® for Substance Use Disorder Admissions
Program effective Date: Nov 02, 2020